Haselmeier, a manufacturer of pen and auto-injection systems, has introduced Axis-D pen platform.
The new injection device, licensed by Merck Serono, a division of Merck, is designed to allow patients to self inject ready to use biopharmaceutical solution.
The Axis pen platform is either made of metal or plastic and is available as a reusable or disposable multi-use pen which features adjustable dosing.
The pen uses technology featuring a sliding dose window which allows easy reading of the dose and provides reduced risk of incorrect dosing.
The Axis pen is compatible with 3ml cartridges, all fill volumes and can be used accordingly to patient needs.
Haselmeier Director Business Development & Marketing Volker Wirth said they added a function to the pen to immediately confirm that a complete dose was delivered, or to indicate the missing amount if an incomplete dose is injected.